Other top stories

Weekly Mind Reader: COVID Strikes Again

January 24, 2025

FDA Approves Spravato Nasal Spray for Major Depressive Disorder

January 23, 2025

Study Highlights Pleiotropic Effects of GLP-1RAs

January 22, 2025

The Road Between The Gut And Schizophrenia Runs Both Ways

January 22, 2025

Could Media Violence Be Driving Antisocial Behavior In Boys?

January 21, 2025

Indoor Temperatures Tied to Cognitive Risks in Older Adults

January 20, 2025

Other stories

Huntington’s Brain Changes Show Up Decades Before Symptoms

January 17, 2025

Weekly Mind Reader: A Quiet Crisis

January 17, 2025

Study Illuminates Impact of Menopause on MS Progression

January 16, 2025

Study Ties COVID to Higher Risk of Chronic Fatigue Syndrome

January 15, 2025

Gut Microbiome Breakthroughs Revolutionize Schizophrenia Treatment

January 15, 2025

US Dementia Cases Will Double By 2060

January 14, 2025

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure. Image of a syringe on two vials highlights aripiprazole monohydrate LAI clinical use in Bipolar I Disorder.

Subscribe to read
more articles

Subscribe